Lilly and former lobbyist resolve sex discrimination suit
In her complaint, the lobbyist had claimed a top executive made sexist comments about her, mocked her physical appearance and subjected her and other women to a hostile work environment.
In her complaint, the lobbyist had claimed a top executive made sexist comments about her, mocked her physical appearance and subjected her and other women to a hostile work environment.
Gil Peri begins his new job just as the system is about to undertake one of its biggest projects in a decade—relocating its maternity services from Methodist Hospital to new, centralized maternity and newborn health unit at Riley Hospital, as part of a $142 million expansion.
The new gadget from VoCare Inc. is about the size of a smart phone and measures a person’s temperature, heart rate, blood pressure, blood glucose levels, blood oxygen saturation and heart rhythms.
Indiana University Health has created a lab to testing the vulnerability of hundreds or even thousands of devices, to protect both patients and the hospital system’s records.
Duane Nickell, a retired science teacher in Indianapolis, decided it was time to collect the stories of 17 prominent Hoosier scientists. What resulted is a book called “Scientific Indiana” that’s hitting stores now.
A vascular surgeon in Bloomington is suing Indiana University, claiming it unfairly revoked his hospital privileges and spread false information about him in an effort to dry up referrals and exert monopoly control in the market.
Mathilde Merlet oversees one of Eli Lilly and Co.’s fastest-growing products, a medicine called Taltz that treats a variety of dermatology and rheumatology disorders.
The Indiana Utility Regulatory Commission on Wednesday unanimously approved the project, which will include 581,594 solar panels and generate 195 megawatts of electricity, making it one of the largest solar farms in the state.
The deal would boost Greenfield-based Elanco’s profile in the billion-dollar pet dermatology market and continue its acquisition strategy.
More than 541,000 free COVID-19 tests have been provided at an OptumServe site since May 6, 2020, the state said last week, when it announced it was closing the vendor’s testing sites at the end of June.
The use of COVID antibodies has fallen across the United States lately and, along with it, Lilly’s sales in that category.
Activist investor Paul Singer says the huge utility has been underperforming its peers and argues that Duke’s customers would be better served by locally managed utilities.
Ascension Technologies, the IT subsidiary of St. Louis-based Ascension, is outsourcing the jobs to overseas companies.
The program was established in 2015 after Scott County generated national headlines for racking up more than 237 cases of HIV in a single year, in a county of just 24,000 people.
Officials still plan to seek City-County Council approval to lift mask mandates for fully vaccinated people on June 7 and hope to further ease other restrictions if the county can reach a 50% vaccination rate by July 4.
In a change of policy, Indiana University Health said Tuesday it will require doctors, nurses and other team members to be fully vaccinated against COVID-19 by Sept. 1.
For decades, one industry—health care—has largely clung to its traditional model of person-to-person visits in brick-and-mortar buildings, even as other industries have gone virtual. It took a pandemic to disrupt everything, almost overnight.
For more than a century, Eli Lilly and Co. has pushed for innovation in the pharmaceutical industry. But six years ago, the drugmaker had to admit it was less than innovative in its own workforce.
Eli Lilly on Thursday said in a government filing that it has received a subpoena from the U.S. Justice Department for documents related to the factory and is cooperating with the investigation.
Zig Therapeutics Inc. wants to raise about $100 million to build a health-digital system that would allow doctors to monitor and adjust the dosing of drugs for patients based on their real-time therapeutic response to a drug.